India initiates anti-dumping probe against Chinese pharma chemical

If it is established that the dumping has caused material injury to the domestic players, the DGTR would recommend the imposition of anti-dumping duty on imports from China. The finance ministry takes the final decision to impose the duties.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news